top of page


LEGA Trial
LowtoxEoxGastricAdvanced
A RANDOMIZED PHASE III STUDY OF LOW-DOCETAXEL OXALIPLATIN, CAPECITABINE (LOW-TOX) VS EPIRUBICIN, OXALIPLATIN AND CAPECITABINE (EOX) IN PATIENTS WITH LOCALLY ADVANCED UNRESECTABLE OR METASTATIC GASTRIC CANCER
· PAPER
Scarica il file
· SOSPENSIONE TEMPORANEA ARRUOLAMENTO LEGA
Scarica il file
· NEWSLETTER LEGA
Scarica il file
· SINOSSI
Scarica il file
bottom of page